Yes, when administered by qualified healthcare professionals
Certain groups are more prone to B12 deficiency, including older adults, individuals with gastrointestinal conditions (such as Crohns disease or celiac disease), those who have undergone gastric surgery, or people with dietary restrictions
All dosing figures describe a documented research protocol, not a prescription or a personal recommendation
n = 8), while a second group received 5A-1MQ treatment at 32 mg/kg of active pharmaceutical ingredient (injections of 4 mg 5A-1MQ monochloride salt/mL sterile saline dosed at 10 mL/kg body weight) after being switched from WD to LD (termed the WD/LD-T group
This is at the very edge of Metabolic & Weight Research
Separate-vial schedules use 250-500 mcg BPC-157 daily, 2.5-5 mg TB-500 twice weekly, and 1-2 mg GHK-Cu daily